TET2 Antibodies

Lei, Wu, Gu, Ji, Yang: "Differences in DNA Methylation Reprogramming Underlie the Sexual Dimorphism of Behavioral Disorder Caused by Prenatal Stress in Rats." in: Frontiers in neuroscience, Vol. 14, pp. 573107, (2020) (PubMed).

Yu, Liu, Liu, Wang, Liu, Miao, Du, Yang: "Ascorbic acid induces global epigenetic reprogramming to promote meiotic maturation and developmental competence of porcine oocytes." in: Scientific reports, Vol. 8, Issue 1, pp. 6132, (2018) (PubMed).

Tucker, Getchell, McCarthy, Ohman, Sasamoto, Xu, Ko, Gupta, Shafrir, Medina, Lee, MacDonald, Malik, Hasselblatt, Li, Zhang, Kaplan, Murphy, Hirsch, Liu, Matulonis, Terry, Lian, Dinulescu: "Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 24, Issue 6, pp. 1389-1401, (2018) (PubMed).

Fischer, Miles: "Silencing HIF-1α induces TET2 expression and augments ascorbic acid induced 5-hydroxymethylation of DNA in human metastatic melanoma cells." in: Biochemical and biophysical research communications, Vol. 490, Issue 2, pp. 176-181, (2017) (PubMed).

Wallner, Schröder, Leitão, Berulava, Haak, Beißer, Rahmann, Richter, Manke, Bönisch, Arrigoni, Fröhler, Klironomos, Chen, Rajewsky, Müller, Ebert, Lengauer, Barann, Rosenstiel, Gasparoni, Nordström et al.: "Epigenetic dynamics of monocyte-to-macrophage differentiation. ..." in: Epigenetics & chromatin, Vol. 9, pp. 33, (2016) (PubMed).

Gong, Guo, Niu, Jin, Zhang, Shi, Zhang, Li, Chen, Ma: "Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma." in: Oncotarget, Vol. 8, Issue 1, pp. 315-328, (2016) (PubMed).

Tsai, Li, Chen, Yeh, Huang, Tseng, Fu, Liou, Pan, Huang, Chen, Chang, Ger, Chang: "Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype." in: Breast cancer research and treatment, Vol. 153, Issue 1, pp. 219-34, (2015) (PubMed).

Orr, Haffner, Nelson, Yegnasubramanian, Eberhart: "Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma." in: PLoS ONE, Vol. 7, Issue 7, pp. e41036, (2012) (PubMed).

Langemeijer, Kuiper, Berends, Knops, Aslanyan, Massop, Stevens-Linders, van Hoogen, van Kessel, Raymakers, Kamping, Verhoef, Verburgh, Hagemeijer, Vandenberghe, de Witte, van der Reijden, Jansen: "Acquired mutations in TET2 are common in myelodysplastic syndromes." in: Nature genetics, Vol. 41, Issue 7, pp. 838-42, (2009) (PubMed).